Cramer's Mad Money - The Ultimate Stealth Rolling Bull Market (11/10/09) [View article]
Actually Cramer's advise is sound. JNJ is dead money for the next 3 years as it will struggle to maintain earnings due to patent expiries and lack of near term pipeline in pharma and medical devices. Their consumer group is doing well but cannot makeup for overall weakness.
On Nov 11 11:10 AM Gravity404 wrote:
> Cramer says he doesn't like JNJ. That means it's time to BUY, BUY,> BUY it. > > Everyone should have JNJ in their portfolios and $60 is a excellent > entry point for long term buyers.
38 Companies with Top Financial Strength [View article]
I ran these through the morningstar database as well. Generally these are companies with "moats" and high financial strength (A or B on a 5 point scale - so consistent with S&P/VL analysis). Only 5 of these are rated as "strong buys" by Morningstar with 4 of 5 having wide moats. I also pleased that I own two of them.
Cramer's Mad Money - The Ultimate Stealth Rolling Bull Market (11/10/09) [View article]
On Nov 11 11:10 AM Gravity404 wrote:
> Cramer says he doesn't like JNJ. That means it's time to BUY, BUY,> BUY it.
>
> Everyone should have JNJ in their portfolios and $60 is a excellent
> entry point for long term buyers.
38 Companies with Top Financial Strength [View article]
Here are the results.
tinyurl.com/mqu5p6